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Studies have shown associations between reduced vitamin K status and poor cognitive function. However,
despite this apparent link, direct studies measuring cognitive function, vitamin K status and inflammation
are lacking. In the current study, The ELDERMET cohort was investigated to identify associations between
cognition, vitamin K status and inflammation. The primary aim of the ELDERMET study was to investigate
the relationship between gut bacteria, diet, lifestyle and health in 500 older Irish adults. Significant
differences in serum phylloquinone, dietary phylloquinone and inflammatory markers were found across
varying levels of cognitive function, after controlling for sex, age, body mass index (BMI), triglycerides and
blood pressure. In addition, significantly higher levels of dietary phylloquinone were found in those with
better cognition compared to those with the poorest function. Higher levels of inflammatory were also
associated with poor cognition. Furthermore, both dietary and serum phylloquinone were significant
independent predictors of good cognitive function, after controlling for confounders. This study highlights
the importance of dietary vitamin K as a potentially protective cognitive factor; it also provides evidence
for the correlation between cognition and inflammation. Strategies should be devised by which elderly
populations can access rich dietary sources of phylloquinone to maintain cognition.
Keywords: Vitamin K, Inflammation, Cognitive function, Elderly
Introduction
Vitamin K is generally known for its role in blood
coagulation and is the general term for a group of
fat-soluble compounds.1 However in recent years, a
number of potential health benefits beyond coagu-
lation have been attributed to vitamin K. While
green leafy vegetables provide phylloquinone (or
vitamin K1), the most widely consumed dietary form
of the vitamin,2 high levels of a menaquinone
(vitamin K2) isoform called menaquinone-4 (MK-4)
have been reported in brain tissues.3 At the biochemi-
cal level, vitamin K is implicated in the production of
sphingolipids, a group of lipids that comprise the
myelin sheath of neuronal tissue3,4 and that are now
recognised as important bioactive mediators of cell
interaction, proliferation, senescence, differentiation
and transformation.5 The vitamin K-dependent
protein (VKDP) Growth-arrest specific gene-6
(Gas6) is present in the brain where it performs cell
regulatory and myelination functions. A role for
vitamin K in memory consolidation has also been
documented. Carrie and colleagues (2011) conducted
a feeding study on female Sprague–Dawley rats fed a
low, adequate and high phylloquinone diet to deter-
mine the effects on spatial memory (using the Morris
water maze test). Animals exposed to a high or ade-
quate phylloquinone diet required less visual assist-
ance to complete the task than rats on the vitamin K
depleted diet.6
Studies in humans have also shown associations
between reduced vitamin K status and poor cognitive
function.7 conducted research on a group of women
with Alzheimer’s Disease; the level of serum phyllo-
quinone was positively associated with Mini Mental
State Exam (MMSE) scores and negatively associated
with uncarboxylated osteocalcin, a bone-derived
VKDP which is also a marker of sub-optimal
vitamin K status. Similarly, differences in dietary phyl-
loquinone intakes have been reported between elderly
patients in the early stages of Alzheimer’s disease com-
pared to healthy controls.8,9 A subsequent study by
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Presse and colleagues revealed that in cognitively
intact elderly individuals, higher serum phylloquinone
concentrations were correlated with enhanced verbal
episodic memory and recollection tests.10 More
recently, studies of older adults have reported better
cognitive function and behavioural rating among
those in the highest quartile of dietary phylloquinone
intake11 and fewer and less severe subjective memory
complaints among those with higher dietary
intakes.12 These findings however appear to be con-
fined to older populations. Analysis of middle-aged,
community-dwelling participants of the Longitudinal
Aging Study in Amsterdam revealed no association
between suboptimal vitamin K status and cognitive
decline.13
Aging and indeed cognitive decline has been associ-
ated with increased systemic inflammation14,15 with
several studies reporting higher circulating levels of
pro-inflammatory cytokines in demented subjects.16–18
Vitamin K has been shown to have anti-inflammatory
properties in both in vitro and in vivo studies19–21 and
its protective effect in maintaining cognitive integrity
is thought to be mediated, in part, through this mech-
anism.22 However despite this apparent link, direct
studies measuring cognitive function, vitamin K
status and inflammation are lacking.
The ELDERMET cohort, a group of well-charac-
terized Irish subjects aged ≥64 years was investigated
in the current study. ELDERMET Subjects were
divided into four groups based on their MMSE score
seeking to identify associations between cognition,
vitamin K status and inflammation (Table 1).
Materials and methods
The ELDERMET cohort
The ELDERMET cohort is a well-defined study group
of Irish adults, aged ≥64 years, ranging from cogni-
tively intact to severely cognitively impaired. This mul-
tifaceted project commenced in 2007 to examine how
intestinal bacteria influence, and are influenced by,
diet, lifestyle and health in 500 older Irish people.
Subjects chosen included those in long-term care
facilities, day-hospital attendees, rehabilitation
patients and community-dwelling volunteers.
Previously, correlations between microbiota compo-
sition, diet, health and frailty status have been reported
in the cohort.23,24 Subjects were clinically assessed at
ELDERMET Clinics at two local hospitals. Subjects
were excluded from the study if they had participated
in medical trials in the previous month, if they had a
history of alcoholism or an advanced organic
disease. Informed consent was obtained from all sub-
jects or from the next of kin of those with cognitive
impairment in accordance with local Clinical
Research Ethics Committee. This study adheres to
the guidelines dictated by the Declaration of
Helsinki and those of the Research Ethics
Committee, Ireland. Subjects underwent a large
number of tests including a validated food-frequency
questionnaire, Mini Mental State exam (MMSE),
mini nutritional assessment (MNA), and a physical
examination; they provided saliva, urine, faecal,
blood samples and a medical history including
Charlson Comorbidity Index (CCI).
Subject selection and classification
A subgroup of the ELDERMET cohort, comprising
156 subjects, was selected for the current study.
Subjects receiving antibiotics were disqualified from
the study due to the impact of antibiotics on the gut
microbiota;25 those treated with vitamin K antagonists
(warfarin and acenocoumarol) were also excluded due
to their effects on long-term markers of vitamin K
status. The mean age of the subject group was 78±
8.5 years, with a range of 64–102 years. Subjects
were grouped based on the MMSE categories as deter-
mined by Poynter et al.,26 which referenced the British
National Institute for Health and Clinical excellence
guidelines. In the current study, quartiles were set at
marginally higher MMSE scores due to a paucity of
subjects in certain categories. The subjects were
grouped according to MMSE number as outlined in
the table below:
Dietary phylloquinone
Dietary data were collected by a trained nurse using a
semi-quantitative Food Frequency Questionnaire
(FFQ). The FFQ selected was a version of that used
by the European Prospective Investigation into
Cancer (EPIC) study27 which had been amended for
use in the Irish population.28 Habitual dietary intake
was determined by assessing the intake of 147 food-
stuffs, the frequency of intake being established using
10 categories ranging from ‘never’ to ‘6 times a day
or more’. The frequency categories were converted to
their proportion of a single daily serving i.e. 0.14 for
‘once a week’. Portion sizes were estimated from a
recent, gender-specific study on portion size.29
Dietary phylloquinone sources with similar levels of
phylloquinone were averaged based on values reported
in the sixth edition of McCance and Widdowson’s The
Composition of Foods30 and Bolton-Smith et al.31 No
Table 1 Classification of ELDERMET subjects into groups
based on MMSE number.
MMSE
category Interpretation Cognitive class
1 MMSE ≤15 Severe cognitive impairment
2 MMSE 16–19 Moderate cognitive
impairment
3 MMSE 20–25 Mild cognitive impairment
4 MMSE 26–30 Good/normal cognition
A. Kiely et al. Vitamin K status and inflammation are associated with cognition in older Irish adults
Nutritional Neuroscience 20182
vitamin K-containing supplements were consumed by
study participants.
Serum phylloquinone
Blood samples were processed and stored following
standard procedures as described elsewhere.23
Individuals were non-fasted and blood samples were
taken by a trained nurse using a vacutainer. Blood
samples were centrifuged and after serum was
extracted samples were stored at −80°C. Serum phyl-
loquinone (vitamin K1) was assessed by reverse
phase HPLC with fluorescence detection as described
by Presse et al.10
High sensitivity C-reactive protein (hsCRP)
A commercially available Quantikine human Enzyme-
Linked Immunoassay (ELISA) kit was used to
measure hsCRP (R & D systems, Oxford, UK).
Samples were assayed in duplicate according to manu-
factures’ guidelines using appropriate standards and
controls. Initially, all samples were assayed using a 1
in 200 dilutions with further dilutions being performed
on high concentration samples. The intra- and inter-
assay coefficients of variation were 3.95% and
4.31%, respectively.
Uncarboxylated osteocalcin (ucOC)
A commercially available Quantikine human ELISA
kit was used to measure carboxylated and uncarboxy-
lated osteocalcin (TaKaRa Bio Inc, Japan). Samples
were assayed in duplicate according to manufactures
guidelines using appropriate standards and controls.
Initially, all samples were assayed using a 1 in 2
dilutions with further dilutions being performed on
high concentration samples. Uncarboxylated osteocal-
cin (%ucOC) was expressed as a percentage of total
osteocalcin (carboxylated+ uncarboxylated osteocal-
cin) as in O’Connor et al.32
The intra- and inter-assay coefficients of variation
for the carboxylated osteocalcin assay were 2.47%
and 2.38%, respectively. The intra- and inter-assay
coefficients of variation for the uncarboxylated osteo-
calcin assay were 3.59% and 3.70%, respectively.
Cytokine analysis
The cytokines IL-6, IL-8 and TNFα were measured
using validated, commercial, multi-spot microplates
(Meso Scale Diagnostics). For more information see
Claesson et al.23
Statistical analysis
Descriptive statistics are presented as mean (SD),
median (25th percentile, 75th percentile) or number
(percentage) as appropriate. Numeric variables were
examined for normality by visual inspection of histo-
grams and formal tests of normality. Demographic
differences between the MMSE categories were
assessed using one-way ANOVA for normally distrib-
uted variables, Kruskal–Wallis test for skewed data,
and Chi-square test of independence for categorical
data.
Analysis of Covariance (ANCOVA) was used to
examine differences in dietary phylloquinone, serum
phylloquinone and inflammatory blood markers (IL-
6, IL-8, IL-10, TNFα and high-sensitivity C-
Reactive) Protein (hsCRP) across the MMSE cat-
egories, controlling for sex, age, BMI, triglycerides
and blood pressure. Bonferroni adjusted pairwise com-
parisons were used to examine between-group differ-
ences. Partial correlations were used to examine the
linear relationships between dietary phylloquinone,
serum phylloquinone and the inflammatory blood
markers (IL-6, IL-8, IL-10 and TNFa), controlling
for sex, age, BMI, triglycerides and blood pressure.
All positively skewed data were normalised using a
natural logarithm transformation prior to analyses.
Diastolic blood pressure was used as the control vari-
able for blood pressure throughout the analyses.
Tertiles of dietary phylloquinone and serum phyllo-
quinone were compared across the MMSE categories
using the Chi-square test of independence.
Hierarchal binary logistic regression analysis was
used to examine if the tertiles of dietary phylloquinone
and serum phylloquinone were predictive of good
cognitive function defined as MMSE group 4
(MMSE 26+). The 5% significance level was used
for all statistical tests. Statistical analyses were per-
formed using IBM SPSS Statistics for Windows,
Version 22.0. Armonk, NY: IBM Corp.
Results
Demographics
The general characteristics of study subjects (n= 156)
are listed in Table 2, while Table 3 outlines the charac-
teristics of subjects across different MMSE categories.
Age, BMI, CCI and blood pressure differed between
MMSE categories (P< .001).
Differences between vitamin K status and
inflammatory markers across MMSE groups
Vitamin K levels and inflammatory markers across the
MMSE groups are presented in Table 4. ANCOVA
analysis identified significant differences in serum
phylloquinone, dietary phylloquinone, IL-6, TNFα
and hsCRP values across the MMSE categories,
after controlling for effects of sex, age, BMI, triglycer-
ides and blood pressure. Pairwise Bonferroni adjusted
post-hoc tests examined differences between the
MMSE groups, controlling for multiple testing.
Results indicated significantly higher levels of dietary
phylloquinone in MMSE groups 4 compared to
group 1 (P= .002) and group 2 (P= .044), and
higher levels in group 3 compared to group 1 (P=
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.036). The inflammatory marker IL-6 was found at sig-
nificantly higher levels in MMSE group 1 compared to
groups 3 (P= .011) and 4 (P= .001). CRP levels in
MMSE group 2 were significantly higher than those
in group 4 (P= .049).
Furthermore, when CCI was included as a control
variable in addition to sex, age, BMI, triglycerides
and blood pressure (albeit in a reduced sample size,
n= 96), differences in dietary phylloquinone
intake remained significant across MMSE categories
(P= .016). Bonferroni adjusted P-values indicated
significantly higher dietary phylloquinone intakes in
group 4 compared to group 1 (P= .042) and group 2
(P= .028).
Relationship between vitamin K status and
inflammatory markers
Partial correlation analysis, controlling for age, sex,
BMI, triglycerides and blood pressure (Table 5)
found a significant weak negative association
between IL-6 and dietary phylloquinone (partial
r=−0.263, P< .01) and serum phylloquinone
(partial r=−0.203, P< .05). Weak to moderate posi-
tive correlations between the markers IL-6, IL-8, IL-10
and TNFα were also identified as significant.
Tertiles of vitamin K status (dietary
phylloquinone and serum phylloquinone)
across the MMSE groups
Tertiles of dietary phylloquinone were computed as
1st tertile: <73 µg, 2nd tertile: 73–121 µg, and 3rd
tertile: >121 µg. Tertiles of serum phylloquinone
were computed as 1st tertile: <0.179 ng/ml, 2nd
tertile: 0.179–0.383 ng/ml, and 3rd tertile:
>0.383 ng/ml. The frequencies and percentages in
the tertile across the MMSE categories are presented
in Figs. 1 and 2. Only 13% of those in the 3rd tertile
of dietary phylloquinone were in MMSE group 1,
compared with 38% of those in the 1st tertile (P<
.001) (Fig. 1). Similarly, only 12% of those in the
3rd tertile of serum phylloquinone were in MMSE
group 1 compared to 42% of those in the 1st tertile
(P< .001) (Fig. 2).
Is vitamin K status predictive of good cognitive
function (MMSE ≥26, group 4)?
Hierarchical binary logistic regression models
(Table 6) were used to examine if the tertiles of
dietary phylloquinone and serum phylloquinone
were predictive of good cognitive function defined
as MMSE group 4 (MMSE 26+), controlling for
potential confounders.
Dietary phylloquinone was a significant indepen-
dent predictor of good cognitive function, controlling
Table 2 Descriptive data presented as mean, standard
deviation or median, interquartile range as appropriate or
number (percentage)
Valid N Descriptive statistics
Gender (% female) 156 100 (64.1%)
Age (years) 154 78.27 (8.54)
BMI (kg/m2) 156 26.09 (5.81)
Diastolic BP (mmHg) 154 73.38 (11.90)
Systolic BP (mmHg) 154 134.12 (20.48)
Cholesterol (mmol/l) 154 4.91 (1.14)
Triglycerides (mmol/l) 154 1.37 (1.04, 1.86)






Serum phylloquinone (nmol/l) 153 0.55 (0.33, 1.12)
Dietary phylloquinone (μg/d) 135 90 (65, 149)
% ucOC 156 34.14 (23.52, 46.21)
IL-6 (IU) 153 7.99 (4.84, 13.10)
IL-8 (IU) 153 16.86 (9.84, 26.75)
IL-10 (IU) 153 5.12 (3.27, 10.00)
TNFα (IU) 153 5.23 (3.93, 7.76)
hsCRP (mg/l) 156 34.64 (13.46, 96.40)
Notes: BMI, Body Mass Index, BP, blood pressure, CCI,
Charlson Co-Morbidity Index: Score out of a total of 22, higher
scores indicate more co-morbidity, MMSE, Mini Mental State
Exam; category 1 MMSE <15= severe cognitive impairment,
category 2 MMSE 16–20=moderate cognitive impairment,
category 3 MMSE 21–25=mild cognitive impairment, category
4 MMSE >26= normal cognitive function, % ucOC, percentage
undercarboxylated osteocalcin, IL-6, interleukin-6, IL-8,
interleukin-8, IL-10, interleukin-10, TNFα, Tumour Necrosis
Factor α, hsCRP, high sensitivity C-Reactive Protein.
Table 3 Between-group comparisons using one way ANOVA or Kruskal Wallis test
MMSE category
1 2 3 4 P-value
Gender (% female) 30 (76.9%) 7 (70%) 25 (58.1%) 38 (59.4%) .238
Age (years) 84.13 (7.56) 85.70 (8.49) 79.66 (6.60) 72.64 (6.43) <.001
BMI (kg/m2) 23.06 (5.04) 20.80 (3.45) 26.90 (5.31) 28.21 (5.67) <.001
Diastolic BP (mmHg) 69.64 (9.70) 62.56 (16.02) 73.31 (13.39) 77.23 (9.86) <.001
Systolic BP (mmHg) 125.36 (16.64) 118.89 (16.41) 133.40 (23.82) 142.06 (17.41) <.001
Cholesterol (mmol/l) 4.81 (1.04) 4.71 (1.46) 4.92 (1.19) 5.00 (1.13) .819
Triglycerides (mmol/l) 1.37 (1.08, 2.48) 1.48 (1.07, 1.92) 1.48 (1.04, 1.99) 1.27 (0.92, 1.65) .1891
CCI 3 (1,4) 3(0, 4) 2 (0, 3) 0 (0, 1) <.0011
Notes: Descriptive data presented as mean (SD), median (25th percentile, 75th percentile) or number (%).
BMI (Body Mass Index), BP (blood pressure), CCI, Charlson Co-morbidity Index: Score out of a total of 22, higher scores indicate
more co-morbidity.
1Kruskal–Wallis test.
A. Kiely et al. Vitamin K status and inflammation are associated with cognition in older Irish adults
Nutritional Neuroscience 20184
for age, BMI, sex, triglycerides and blood pressure
(Model 2, P= .038). The odds ratios for good cogni-
tive function for second and third tertiles of dietary
phylloquinone compared to the first tertile were
OR= 1.01 (95% CI: 0.311, 3.68) and OR= 4.03
(95%CI: 1.19, 13.65), respectively.
Serum phylloquinone was a significant indepen-
dent predictor of good cognitive function,
controlling for age, BMI, sex, triglycerides and
blood pressure (Model 2, P= .022). The odds
ratios for good cognitive function for second and
third tertiles of serum phylloquinone compared to
the first tertile were OR= 4.24 (95% CI: 1.31,
13.68) and OR= 5.15 (95% CI: 1.49, 17.76),
respectively.
Including IL-6, TNFα and hsCRP as measures of
inflammation in the hierarchical models (Model 3),
the tertiles of serum phylloquinone were close to
achieving significance as independent predictors of
good cognitive function (P= .057). The odds ratio
for good cognitive function for the second and third
tertiles of serum phylloquinone compared to the first
tertile were OR= 3.84 (95% CI: 1.07, 13.72) and
OR= 4.75 (95% CI: 1.23, 18.37) respectively, control-
ling for age, sex, triglycerides, blood pressure and
inflammation (IL-6, CRPs and TNFα).
Discussion
Summary of main findings
Research has linked vitamin K status with psychomo-
tor behaviour and cognition.6,7,10 In the current study,
relationships between cognitive function, vitamin K
status and inflammation were investigated to further
investigate the association between vitamin K status
and cognitive function. Significant differences in
dietary phylloquinone intake and the inflammatory
marker IL-6 between cognitive function groups were
found, controlling for sex, age, body mass index, tri-
glycerides and blood pressure. Furthermore, serum
phylloquinone significantly and independently pre-
dicted good cognitive function after controlling for
the same confounding variables. In addition, when
controlling for inflammation, serum phylloquinone
Table 4 Analysis of covariance (ANCOVA) of differences across Mini Mental State Exam (MMSE) categories
MMSE category





0.34 (0.25, 0.61) 0.54 (0.33, 1.05) 0.49 (0.24, 1.12) 0.77 (0.46, 1.31) .049
Dietary phylloquinone
(µg/d)
75.50 (55.00, 94.50) 71.50 (44.00, 86.00) 91.00 (61.00, 151.00) 136.50 (78.00, 252.00) .002a,b,c
%ucOC 39.89 (21.41) 38.13 (20.19) 41.08 (22.16) 31.68 (13.83) .060
IL-6 (IU) 13.33 (8.49, 34.83) 12.10 (5.93, 18.27) 8.06 (4.67, 10.00) 5.41 (3.75, 8.25) .001a,b
IL-8 (IU) 27.12 (17.96, 36.00) 22.29 (5.22, 29.36) 16.98 (11.80, 28.83) 13.32 (7.85, 18.82) .094
IL-10 (IU) 7.00 (4.61, 13.00) 7.29 (5.35, 17.57) 4.72 (2.88, 10.50) 4.01 (2.92, 6.17) .198
TNFα (IU) 7.76 (6.00, 9.75) 7.11 (4.90, 10.17) 4.38 (3.85, 6.00) 4.56 (3.47, 6.27) .039
hsCRP (mg/l) 57.39 (32.10, 154.24) 78.34 (47.40, 186.08) 42.39 (15.50, 154.86) 19.62 (8.53, 39.81) .015c
Notes: Descriptive data presented as median (25th percentile, 75th percentile) or mean (SD).
1ANCOVA controlling for sex, age, BMI, triglycerides and blood pressure, 2Serum phylloquinone, dietary phylloquinone, IL-6, IL-8, IL-
10, TNFα and hsCRP were transformed to normality using the natural logarithm. Significant post-hoc Bonferroni adjusted pairwise
comparisons: agroups 1 and 4, bgroups 1 and 3, cgroups 2 and 4, dgroups 3 and 4.
% ucOC, percentage undercarboxylated osteocalcin, IL-6, interleukin-6, IL-8, interleukin-8, IL-10, interleukin-10, TNFα, Tumour
Necrosis Factor α, hsCRP, High sensitivity C-Reactive Protein.
Table 5 Partial correlations controlling for sex, age, BMI, triglycerides and blood pressure
Serum phylloquinone Dietary phylloquinone %ucOC IL-6 IL-8 IL-10 TNFα hsCRP
Serum phylloquinone 1.000
Dietary phylloquinone .253** 1.000
%ucOC −.169 −.046 1.000
IL-6 −.203* −.263** .057 1.000
IL-8 -.118 −.161 .200* .036 1.000
IL-10 −.106 −.090 .094 .453** .281** 1.000
TNFα −.187* −.120 .056 .314** .389** .394** 1.000
hsCRP −.146 −.099 .037 .411** .074 .151 .067 1.000
Note: Partial correlations controlling for sex, age, BMI, triglycerides and blood pressure (serum phylloquinone, dietary phylloquinone,
IL-6, IL-8, IL-10 and TNFα were transformed using the natural logarithm).
BMI, Body Mass Index, % ucOC, percentage uncarboxylated osteocalcin, IL-6, interleukin-6, IL-8, interleukin-8, IL-10, interleukin-10,
TNFα, Tumour Necrosis Factor α, hsCRP, high sensitivity C-Reactive Protein.
*P< .05, **P< .01.
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remained a significant and independent predictor of
cognitive function.
Alignment to literature
In line with previous studies,8,9,11,33 dietary phylloqui-
none varied according to cognitive ability with those
having the poorest cognitive function also having the
lowest dietary vitamin K intake. The median daily
intake of dietary phylloquinone among the present
study cohort was 90 µg (65, 149) Duggan et al.;34
Hayes et al.35 reported slightly lower intakes among
a representative sample of Irish ≥65 yr olds from the
National Adults Nutrition Survey with median
intakes of 72.4 µg (47–109). Combined evidence from
both studies shows insufficient dietary phylloquinone
intakes among elderly individuals relative to the
current US and Canadian guidelines for dietary phyl-
loquinone intake of 120 µg and 90 µg for males and
females, respectively.36 This highlights the fact that
elderly populations may have insufficient dietary
intakes in order to facilitate full functionality of
vitamin K-dependent proteins, regulate inflammatory
processes and sphingolipid synthesis thus limiting
their influence on cognitive integrity.
We found significant differences in dietary phylloqui-
none between groups with different cognitive ability. In
fact, dietary phylloquinonewas the only discriminatory
measure of vitamin K status between the different cog-
nitive groups after controlling for sex, age, BMI, trigly-
cerides and blood pressure. Presse et al.8 measured
dietary vitamin K in a group of subjects with early
onset Alzheimer’s disease (AD) matched with 31
healthy controls of the same age. Significant differences
were found between subjects with mean phylloquinone
intakes of 63 µg/day in subjects withADand intakes of
139 µg/day in the control group. In addition, Chouet
and colleagues11 reported associations between higher
dietary phylloquinone and better cognition among
older adults who participated in the CLIP study, an
observational cross-sectional study designed to
examine the relationships between neuro-cognition
and lipophilic vitamins among all patients consecu-
tively hospitalized or seen in consultation in the geria-
tric acute care unit of the University Hospital of
Angers, France, from February to April 2014, and
found an inverse association between the frontotem-
poral behavioural rating scale (FBRS) for physical
neglect and dietary vitamin K levels; the FBRS is a
reliable, reproducible indicator of the presence of symp-
toms of behavioural disturbance across four domains
(i.e. self-control disorder, physical neglect, mood dis-
orders and loss of general).
In the present study, a moderately positive associ-
ation was observed between MMSE scores and tertiles
of serum phylloquinone. This association was only
found for tertile analyses but not between groups com-
pared across varying levels of cognitive function, after
controlling for potential confounders, and may have
been weakened due to the non-fasted nature of the
samples used in the current analysis. These results
are however in agreement with the observations of
Sato et al.7 who reported a positive association
between MMSE and serum phylloquinone in 100
females AD patients (aged 80y) and age-matched con-
trols. Furthermore, in the current study serum phyllo-
quinone was significantly different between MMSE
categories specifically between those with severe cogni-
tive decline (MMSE< 15) and those with optimum
functionality (MMSE> 26), with median values of
0.34 [0.25, 0.61] ng/ml (0.75 nmol/l) and 0.77 [0.46,
1.31] ng/ml (1.70 nmol/l), respectively. Analysis con-
ducted by Presse et al.10 showed that an increase in
serum phylloquinone concentration from 0.27 to
1.06 nmol/l was associated with an increase in per-
formance in verbal episodic memory test scores in
Figure 1 Tertiles of dietary phylloquinone (µg/d) versus Mini
Mental State Exam (MMSE) grouping.
Figure 2 Tertiles of serum phylloquinone (nmol/ml) versus
Mini State Exam (MMSE) grouping.
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203 subjects from the NuAge study; a 5-year longitudi-
nal study of 1793 older adults designed to assess the
pivotal role of nutrition on physical and cognitive
status, functional autonomy and social functioning.
The same study showed the association between episo-
dic memory performance and serum phylloquinone
concentration to be a logarithmic function and that
the rate of improvement slowed down considerably
after the threshold level of 1 nmol/l. Our data
showed a similar trend; the highest serum phylloqui-
none levels were significantly and independently pre-
dictive of good cognitive function after controlling
for potential confounders. The odds of having better
cognitive function (for tertile 3) were greater than
four times the odds of having good cognitive function
in the poorest cognitive category. Even when control-
ling for inflammation across cognitive categories,
serum phylloquinone remained a significant and inde-
pendent predictor of cognitive function.
Declining cognitive function has been associated
with increased systemic inflammation and inflamma-
tory biomarkers.14–18,37 Wichmann et al.38 found
that those with higher pro-inflammatory IL-6 levels
were at a greater risk of cognitive impairment in an
elderly cohort where cognitive impairment was classi-
fied as an MMSE value of less than 24. Subjects were
monitored over a 20 year period and each doubling of
IL-6 was associated with a greater risk of cognitive
impairment. Similarly, Sudheimer et al.39 found that
elevated IL-6 and TNFα values were associated with
smaller hippocampal volumes, an indicator of cogni-
tive decline with no such correlations reported for
IL-8. However Baune et al.40 found that increased
serum concentrations of IL-8 were associated with
poor performance in the memory and speed domains
of an elderly cohort (determined by 3-word recall
tests and the Stroop colour-word test) with no such
correlations reported between IL-6, TNFα. In the
current study, tertiles of dietary phylloquinone and
serum phylloquinone were found to be predictive of
good cognition (MMSE score of 26 or higher), con-
trolling for age, sex, BMI, blood pressure and trigly-
cerides. While the inclusion of inflammatory markers
(IL-6, TNFα and hs-CRP) in the statistical models
reduced this significance of the association, a similar
albeit non-significant trend was still evident. In
another study, Shea et al.21 showed that dietary phyl-
loquinone intake was associated with circulating IL-6
levels in an older population with average age of 59
years (n= 1381, 669 males and 712 females). The
precise mechanism(s) by which vitamin K exerts its
anti-inflammatory potential are not entirely under-
stood. However, it has been suggested that this
fat-soluble vitamin may downregulate NF-Kb acti-
vation, inhibiting the production of pro-inflammatory
cytokines including IL-6 and other cytokines.41
Table 6 Logistic regression analysis of the association between Good Cognition (MMSE≥ 26) and Dietary and Serum
Phylloquinone Tertiles
Model 1 Model 2 Model 3
OR (95% CI) P-value OR(95% CI) P/-value OR (95% CI) P-value
Dietary 1st 1 <.001 1 .038 1 .118
Phylloquinone 2nd 1.42 (0.55, 3.69) 1.01 (0.311, 3.68) 1.77 (0.43, 7.29)
Tertiles 3rd 5.25 (2.09, 13.20) 4.03 (1.19, 13.65) 4.07 (1.05, 15.81)
Sex Male 1 .866 .347
Female 1.09 (0.39, 3.04) 0.79 (0.30, 2.14)
Age 0.82 (0.76, 0.89) <.001 0.83 (0.76, 0.91) <.001
BMI 1.08 (0.98,1.19) .107 1.13 (1.01, 1.27) .041
Diastolic BP 1.03 (0.99, 1.08) .148 1.04 (0.99, 1.10) .152
Triglycerides 0.34 (0.079, 1.502) .156 0.27 (0.04, 1.96) .195
TNFα 3.81 (1.17, 12.39) .026
IL-6 0.39 (0.17, 0.90) .028
hsCRP 0.55 (0.32, 0.96) .034
Serum st 1 <.001 1 .022 1 .057
Phylloquinone 2nd 4.56 (1.85, 11.24) 4.24 (1.31, 13.68) 3.84 (1.07, 13.74)
Tertiles 3rd 6.01 (2.42, 14.91) 5.15 (1.49, 17.76) 4.75 (1.23, 18.37)
Sex Male 1 .991 1 .647
Female 1.01 (0.41, 2.47) 1.26 (0.47, 3.39)
Age 0.85 (0.79, 0.92) <.001 0.85, (0.78, 0.93) <.001
BMI 1.09 (0.99, 1.19) .074 1.12 (1.01, 1.24) .035
Diastolic BP 1.03 (0.99, 1.07) .150 1.02 (0.98, 1.07) .358
Triglycerides 0.10 (0.02, 0.48) .004 0.08 (0.01, 0.53) .009
TNFα 3.11 (1.13, 8.57) .029
IL-6 0.45 (0.22, 0.95) .037
hsCRP 0.69 (0.44, 1.07) .098
Model 2: Controlling for sex, age, BMI, Diastolic BP and Triglycerides.
Model 3: Controlling for sex, age, BMI, Diastolic BP, Triglycerides, TNFα, IL-6 and hsCRP.
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Strengths and limitations
The current study highlights the importance of consid-
ering vitamin K as a nutritional factor which may have
implications for cognitive health; it also provides com-
prehensive evidence for the correlation between cogni-
tion and inflammation. There are a number of
limitations to the current study; as outlined above,
the community-dwelling elderly individuals were a
self-selected, motivated cohort and may therefore
have had superior dietary and lifestyle factors com-
pared to more general, elderly populations.
Furthermore, we were not able to control for some
variables which may have confounded our findings
including number of years in education, comorbidity,
and dietary diversity. Finally, caution must be exer-
cised when interpreting the results from this study
due to the cross-sectional nature of the study design.
Implications for future research and clinical
practice
Considering 60% of participants with a dietary phyllo-
quinone intake of >121 µg/d had superior cognitive
function, compared to 22% with intakes <73 µg/d,
our data support current dietary intake recommen-
dations of 90–120 µg/day. Given these and other
data supporting the role of dietary vitamin K and pres-
ervation of cognitive function, strategies should be
devised by which elderly populations can access rich
dietary sources of phylloquinone to maintain cognitive
function in later life. Longitudinal, prospective studies
are required to elucidate the relationship between
vitamin K status, inflammation and cognitive
decline, and to understand the mechanisms by which
this could occur.
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